CT imaging interval after complete cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (HIPEC) for well-differentiated adenocarcinoma of the appendix (WDAA).

@article{Beaty2012CTII,
  title={CT imaging interval after complete cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (HIPEC) for well-differentiated adenocarcinoma of the appendix (WDAA).},
  author={K. Beaty and J. Hill and S. Rafeeq and M. Overman and T. Sagebiel and A. Matamoros and R. Royal and P. Mansfield and K. Fournier},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2012},
  volume={30 4_suppl},
  pages={434}
}
  • K. Beaty, J. Hill, +6 authors K. Fournier
  • Published 2012
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 434 Background: WDAA with peritoneal dissemination (PD) is a rare disease with a prognosis related to the ability to perform adequate cytoreductive surgery (CRS) with cytoreductive scores of 0 or 1 (CC0 or CC1) followed by HIPEC. Diagnostic imaging is an important aspect of post-operative surveillance. Often, surveillance imaging follows metastatic colon cancer guidelines with frequent CT scans performed during the first 5 years after resection (every 3 months for 2 years, then every 6 months… CONTINUE READING

    Topics from this paper